Area of research
Cancer Research · Surgery
Research interest
Research interests include Medicine, Internal medicine, Metastatic breast cancer, Randomized controlled trial, Breast cancer, and Oncology.
Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced Neuropathy
Improved pathogen identification in sepsis or septic shock by clinical metagenomic sequencing
ENABLE—App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled Trial
Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease
The correlation of age and extension length in DeBakey type I aortic dissection: are older patients over 70 years at a lower risk?
Overall morbidity after total minimally invasive keyhole oesophagectomy versus hybrid oesophagectomy (the MICkey trial): study protocol for a multicentre randomized controlled trial
The EVIglance randomized clinical trial: a new standard for answering a clinical question
Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment
Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer
Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765)
1552O Chemotherapy-induced peripheral neuropathy (CIPN) prevention trial evaluating the efficacy of hand-cooling and compression in patients undergoing taxan-based (neo-)adjuvant chemotherapy for primary breast cancer: First results of the prospective, randomized POLAR trial
Early intervention, treatment and rehabilitation of employees with common mental disorders by using psychotherapeutic consultation at work: study protocol of a randomised controlled multicentre trial (friaa project)
Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients
Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study
Prediction of mortality rate in acute type A dissection: the German Registry for Acute Type A Aortic Dissection score
HER2-targeted therapy influences CTC status in metastatic breast cancer
Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer
The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer
Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages
Vergleich elektronischer Fragebögen zur gesundheitsbezogenen Lebensqualität (HRQoL) beim metastasierten Mammakarzinom
Therapieevaluation palliativer Chemotherapien beim metastasierten Mammakarzinom anhand des web-basierten EQ-VAS Scores
Receptor discordance between primary tumor and metastasis influences CTC-status
Refining scores based on patient reported outcomes – statistical and medical perspectives
Correlation of microRNA expression in matched-paired primary tumor, metastasis and plasma samples of metastatic breast cancer patients
Development and psychometric validation of a shorter version of the Breast Cancer Treatment Outcome Scale (BCTOS-12)